Müller-Tidow and colleagues perform a randomized clinical trial and show that administration of convalescent plasma improves COVID-19 outcome in patients with cancer who are unable to generate an adequate immune response.
- Claudia M. Denkinger
- Maike Janssen
- Carsten Müller-Tidow